Nomura Holdings’s Zomedica Corp. ZOM Stock Holding History

Nomura Holdings’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-150,000	Closed	-$124K	–	2386
2021 Q2	$124K	Buy	+150,000	New	+$140K	﹤0.01%	1809

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's ZOM Position: Q3 2021 in Review

Nomura Holdings sold out of Zomedica Corp. (ZOM) in Q3 2021, closing a stake of 150,000 shares — an estimated $124K sold.

Nomura Holdings first reported a position in ZOM in Q2 2021 and held it in 1 quarter. The position peaked at $124K in Q2 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q3 2021.

Nomura Holdings reported no remaining Zomedica Corp. position as of Q3 2021 after selling out during the quarter.
Nomura Holdings sold 150,000 Zomedica Corp. shares in Q3 2021, an estimated $124K.
Nomura Holdings first reported a position in Zomedica Corp. in Q2 2021 and held it in 1 quarter.
Nomura Holdings's Zomedica Corp. position peaked at $124K in Q2 2021.
107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2021.

Based on Nomura Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.